http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UA-54335-U

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_afd5066ed5406b87a03dbc3fa5bd7817
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_43cb0a285ede860dafd1f6c737977fac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5d1284b258649fdf9078a2483e94eb3f
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-616
filingDate 2010-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_598dbff93e041c96a830d37a139f6dc5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5afc8c85341f0c7ff9c4f92ac64501a5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_986d96369d6b39fbca805b2a9c29e528
publicationDate 2010-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber UA-54335-U
titleOfInvention PHARMACEUTICAL COMPOSITION FOR TREATMENT OF CEREBROVASCULAR DISORDERS
abstract Pharmaceutical composition for the treatment of diseases of the central nervous system caused by disorders of the cerebral circulation, has nootropic, antiplatelet and cerebroprotective effect. The therapeutically effective amount of piracetam and the therapeutically effective amount of acetylsalicylic acid were used as the active substances.
priorityDate 2010-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556224
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506254
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4843

Total number of triples: 20.